Vera Therapeutics (VERA) Gains from Investment Securities (2022)

Vera Therapeutics (VERA) posted Gains from Investment Securities of $127000.0 for Q3 2022, down 9.29% on a QoQ basis from $140000.0 in Q2 2022.

Vera Therapeutics (VERA) Gains from Investment Securities (2022) Analysis & Trends

Vera Therapeutics' Gains from Investment Securities history runs 1 years deep, the most recent figure standing at $127000.0 for Q3 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	66,621.14 Bn	66,620.85 Bn	-
2	Nanobiotix	1,915.18 Bn	1,915.11 Bn	-
3	Akari Therapeutics	1,014.18 Bn	1,014.18 Bn	-
4	BeOne Medicines	471.27 Bn	466.48 Bn	1.35 Bn
5	Vertex Pharmaceuticals	121.81 Bn	114.57 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	69.58 Bn	60.82 Bn	3.31 Bn
7	Belite Bio	62.72 Bn	62.72 Bn	-
8	Argenx Se	55.51 Bn	50.33 Bn	1.41 Bn
9	Revolution Medicines	37.35 Bn	37.35 Bn	-
10	Vera Therapeutics	2.53 Bn	2.53 Bn	-

Download Data